FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131567029> ?p ?o ?g. }

• W2131567029 endingPage "123" @default.
• W2131567029 startingPage "118" @default.
• W2131567029 abstract "Abstract Few articles have been published on the imaging findings of anaplastic lymphoma kinase ( ALK )‐positive non‐small‐cell lung cancer ( NSCLC ). To investigate the radiological findings of ALK ‐positive NSCLC in the advanced stage, CT scans were examined. In addition, the response to chemotherapy was evaluated. Of the 36 patients with ALK ‐rearranged NSCLC , a mass and a nodule were identified in 17 (47.2%) and 16 (44.4%), respectively, indicating that more than 40% had a small‐sized tumor. Overall, 31 (86.1%) patients had lymphadenopathy, seven (19.4%) had extranodal lymph node invasion, and three (8.3%) had lymphangitis. A pleural effusion was seen in 15 patients (41.7%). All but one patient had no ground‐glass opacity ( GGO ) lesions, indicating that most ALK ‐positive tumors showed a solid growth pattern without GGO on CT . Twenty were evaluable for response to chemotherapy; 10 (50.0%) had a partial response ( PR ), nine (45.0%) had stable disease ( SD ), and one (5.0%) had progressive disease ( PD ) with first‐line chemotherapy. With second‐line chemotherapy, five (26.3%) had PR , 11 (57.9%) had SD , and three (15.8%) had PD . The five patients with PR were all treated by using crizotinib. Time to progression was 8.2 months with first‐line chemotherapy, and 6.0 months with second‐line chemotherapy. Advanced‐stage ALK ‐positive tumors have a relatively aggressive phenotype, which cannot be inferred from the size of the tumor alone. ALK ‐positive patients have a good response to first‐line cytotoxic drugs and to crizotinib as second‐line therapy, but a relatively poor response to cytotoxic drugs as second‐line therapy." @default.
• W2131567029 created "2016-06-24" @default.
• W2131567029 creator A5002327424 @default.
• W2131567029 creator A5002997737 @default.
• W2131567029 creator A5004885422 @default.
• W2131567029 creator A5007279449 @default.
• W2131567029 creator A5022161249 @default.
• W2131567029 creator A5029393521 @default.
• W2131567029 creator A5043986012 @default.
• W2131567029 creator A5053773586 @default.
• W2131567029 creator A5065196329 @default.
• W2131567029 creator A5066754616 @default.
• W2131567029 creator A5068792857 @default.
• W2131567029 creator A5086229141 @default.
• W2131567029 date "2013-12-27" @default.
• W2131567029 modified "2023-09-27" @default.
• W2131567029 title "Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy" @default.
• W2131567029 cites W1990224409 @default.
• W2131567029 cites W1991769983 @default.
• W2131567029 cites W2048065486 @default.
• W2131567029 cites W2054351008 @default.
• W2131567029 cites W2055402151 @default.
• W2131567029 cites W2094903176 @default.
• W2131567029 cites W2097084241 @default.
• W2131567029 cites W2118112346 @default.
• W2131567029 cites W2121005606 @default.
• W2131567029 cites W2134787029 @default.
• W2131567029 cites W2139110945 @default.
• W2131567029 cites W2168106545 @default.
• W2131567029 doi "https://doi.org/10.1002/cam4.172" @default.
• W2131567029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3930396" @default.
• W2131567029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24403104" @default.
• W2131567029 hasPublicationYear "2013" @default.
• W2131567029 type Work @default.
• W2131567029 sameAs 2131567029 @default.
• W2131567029 citedByCount "19" @default.
• W2131567029 countsByYear W21315670292014 @default.
• W2131567029 countsByYear W21315670292015 @default.
• W2131567029 countsByYear W21315670292016 @default.
• W2131567029 countsByYear W21315670292017 @default.
• W2131567029 countsByYear W21315670292018 @default.
• W2131567029 countsByYear W21315670292019 @default.
• W2131567029 countsByYear W21315670292020 @default.
• W2131567029 countsByYear W21315670292021 @default.
• W2131567029 countsByYear W21315670292022 @default.
• W2131567029 crossrefType "journal-article" @default.
• W2131567029 hasAuthorship W2131567029A5002327424 @default.
• W2131567029 hasAuthorship W2131567029A5002997737 @default.
• W2131567029 hasAuthorship W2131567029A5004885422 @default.
• W2131567029 hasAuthorship W2131567029A5007279449 @default.
• W2131567029 hasAuthorship W2131567029A5022161249 @default.
• W2131567029 hasAuthorship W2131567029A5029393521 @default.
• W2131567029 hasAuthorship W2131567029A5043986012 @default.
• W2131567029 hasAuthorship W2131567029A5053773586 @default.
• W2131567029 hasAuthorship W2131567029A5065196329 @default.
• W2131567029 hasAuthorship W2131567029A5066754616 @default.
• W2131567029 hasAuthorship W2131567029A5068792857 @default.
• W2131567029 hasAuthorship W2131567029A5086229141 @default.
• W2131567029 hasBestOaLocation W21315670291 @default.
• W2131567029 hasConcept C117643217 @default.
• W2131567029 hasConcept C126322002 @default.
• W2131567029 hasConcept C142724271 @default.
• W2131567029 hasConcept C143998085 @default.
• W2131567029 hasConcept C146357865 @default.
• W2131567029 hasConcept C151730666 @default.
• W2131567029 hasConcept C2776232967 @default.
• W2131567029 hasConcept C2776256026 @default.
• W2131567029 hasConcept C2776694085 @default.
• W2131567029 hasConcept C2778347629 @default.
• W2131567029 hasConcept C2778822529 @default.
• W2131567029 hasConcept C2779338263 @default.
• W2131567029 hasConcept C2779422266 @default.
• W2131567029 hasConcept C2779634585 @default.
• W2131567029 hasConcept C71924100 @default.
• W2131567029 hasConcept C86803240 @default.
• W2131567029 hasConceptScore W2131567029C117643217 @default.
• W2131567029 hasConceptScore W2131567029C126322002 @default.
• W2131567029 hasConceptScore W2131567029C142724271 @default.
• W2131567029 hasConceptScore W2131567029C143998085 @default.
• W2131567029 hasConceptScore W2131567029C146357865 @default.
• W2131567029 hasConceptScore W2131567029C151730666 @default.
• W2131567029 hasConceptScore W2131567029C2776232967 @default.
• W2131567029 hasConceptScore W2131567029C2776256026 @default.
• W2131567029 hasConceptScore W2131567029C2776694085 @default.
• W2131567029 hasConceptScore W2131567029C2778347629 @default.
• W2131567029 hasConceptScore W2131567029C2778822529 @default.
• W2131567029 hasConceptScore W2131567029C2779338263 @default.
• W2131567029 hasConceptScore W2131567029C2779422266 @default.
• W2131567029 hasConceptScore W2131567029C2779634585 @default.
• W2131567029 hasConceptScore W2131567029C71924100 @default.
• W2131567029 hasConceptScore W2131567029C86803240 @default.
• W2131567029 hasIssue "1" @default.
• W2131567029 hasLocation W21315670291 @default.
• W2131567029 hasLocation W21315670292 @default.
• W2131567029 hasLocation W21315670293 @default.
• W2131567029 hasLocation W21315670294 @default.
• W2131567029 hasOpenAccess W2131567029 @default.
• W2131567029 hasPrimaryLocation W21315670291 @default.

• next